Brighton Jones’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$497K Sell
2,147
-186
-8% -$46K 0.01% 813
2026
Q2
$562K Buy
2,333
+758
+48% +$166K 0.01% 746
2026
Q1
$298K Buy
+1,575
New +$275K 0.01% 938
2022
Q3
– Sell
-1,294
Closed -$202K – 489
2022
Q2
$202K Buy
+1,294
New +$199K 0.01% 427
2021
Q3
– Sell
-1,323
Closed -$235K – 503
2021
Q2
$235K Buy
1,323
+3
+0.2% +$520 0.01% 415
2021
Q1
$217K Buy
1,320
+8
+0.6% +$1.32K 0.01% 386
2020
Q4
$217K Buy
+1,312
New +$195K 0.01% 353
2020
Q1
– Sell
-1,409
Closed -$210K – 306
2019
Q4
$210K Buy
+1,409
New +$192K 0.02% 300
2018
Q4
– Sell
-1,314
Closed -$221K – 278
2018
Q3
$221K Sell
1,314
-2
-0.2% -$344 0.03% 253
2018
Q2
$227K Sell
1,316
-44
-3% -$7.19K 0.03% 269
2018
Q1
$205K Buy
+1,360
New +$200K 0.03% 273
2017
Q3
– Sell
-1,368
Closed -$213K – 300
2017
Q2
$213K Buy
+1,368
New +$209K 0.03% 252
2016
Q3
– Sell
-1,507
Closed -$213K – 239
2016
Q2
$213K Sell
1,507
-67
-4% -$9.9K 0.04% 190
2016
Q1
$205K Sell
1,574
-224
-12% -$27.9K 0.04% 194
2015
Q4
$253K Buy
+1,798
New +$249K 0.05% 164
2015
Q1
– Sell
-1,307
Closed -$214K – 195
2014
Q4
$214K Sell
1,307
-1,410
-52% -$234K 0.05% 179
2014
Q3
$436K Sell
2,717
-21
-0.8% -$3.23K 0.1% 116
2014
Q2
$403K Buy
2,738
+7
+0.3% +$971 0.09% 114
2014
Q1
$379K Hold
2,731
– – 0.09% 115
2013
Q4
$346K Sell
2,731
-513
-16% -$53.1K 0.08% 123
2013
Q3
$298K Buy
+3,244
New +$262K 0.08% 115

Other funds holding JAZZ

Brighton Jones's JAZZ Position: Q3 2026 in Review

Brighton Jones reduced its Jazz Pharmaceuticals (JAZZ) stake by 8% in Q3 2026, selling an estimated $46K and leaving 2,147 shares worth $497K. The position accounts for 0.01% of the portfolio, ranked #813.

Brighton Jones first reported a position in JAZZ in Q3 2013 and has held it in 21 quarters since. The position peaked at $562K in Q2 2026. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Brighton Jones held 2,147 shares of Jazz Pharmaceuticals worth $497K as of Q3 2026.
  • Brighton Jones sold 186 Jazz Pharmaceuticals shares in Q3 2026, an estimated $46K.
  • Jazz Pharmaceuticals made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #813 holding.
  • Brighton Jones first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 21 quarters since.
  • Brighton Jones's Jazz Pharmaceuticals position peaked at $562K in Q2 2026.
  • 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.